We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
AWM
851
Apollon Wealth Management
South Carolina
$4.18M +$10.6K +19 +0.2%
RIM
852
Redpoint Investment Management
Australia
$4.18M -$979K -1,749 -17%
ZB
853
Zions Bancorporation
Utah
$4.17M +$107K +191 +2%
TCOO
854
Trust Company of Oklahoma
Oklahoma
$4.17M -$48.7K -87 -1%
BIMC
855
Benson Investment Management Company
Virginia
$4.16M -$33.6K -60 -0.7%
SAM
856
Synergy Asset Management
Washington
$4.15M +$4.58M +8,189 New
IWA
857
IBEX Wealth Advisors
New Jersey
$4.15M -$156K -279 -3%
CNC
858
Canandaigua National Corp
New York
$4.15M -$22.4K -40 -0.5%
CAM
859
Cresset Asset Management
Illinois
$4.13M -$742K -1,326 -14%
WIC
860
WealthBridge Investment Counsel
Alberta, Canada
$4.12M +$327K +585 +8%
PCA
861
Pallas Capital Advisors
Massachusetts
$4.1M +$218K +390 +5%
IB
862
Iyo Bank
Japan
$4.09M
HCA
863
Harbour Capital Advisors
Virginia
$4.08M +$7.28K +13 +0.2%
BHIA
864
Birch Hill Investment Advisors
Massachusetts
$4.06M -$2.8K -5 -0.1%
PNAA
865
Pictet North America Advisors
Switzerland
$4.06M -$301K -538 -6%
WWM
866
Western Wealth Management
Colorado
$4.06M +$1.38M +2,473 +45%
BRM
867
Boston Research & Management
Massachusetts
$4.05M +$72.8K +130 +2%
MGIA
868
Moneta Group Investment Advisors
Missouri
$4.05M -$305K -545 -6%
SB
869
Simmons Bank
Arkansas
$4.04M -$418K -747 -9%
AIM
870
Anchor Investment Management
South Carolina
$4.02M -$110K -197 -2%
CBB
871
Citizens Business Bank
California
$4.01M -$66K -118 -1%
LIM
872
Leavell Investment Management
Alabama
$3.99M -$49.2K -88 -1%
SA
873
Strategic Advisors
New York
$3.98M -$47.6K -85 -1%
LRIC
874
Long Road Investment Counsel
Michigan
$3.98M
FM
875
Foster & Motley
Ohio
$3.96M -$50.4K -90 -1%

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.